Bioventus Inc. Class A (BVS)
Summary
Are Medical Stocks Lagging Bioventus (BVS) This Year?
Here is how Bioventus (BVS) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.
Is Bioventus (BVS) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bioventus Q2 Earnings Call Highlights
Bioventus NASDAQ: BVS reported second-quarter 2026 revenue growth of 4% and reiterated its full-year financial outlook, citing double-digit expansion in its Pain Treatments business, continued debt reduction and increased investment in platelet-rich plasma, peripheral nerve stimulation, Ultrasonics and international operations.
Bioventus Inc. Class A Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 92 | $747.26 | $1,199.22 | $451.96 | 60.48% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 13,171 | $124,330 | $173,318.51 | $48,988.51 | 39.4% |
| NA Nizar Araji National Bank Of Canada /FI/ | 800 | $5,456 | $11,300 | $5,844 | 107.11% |
| SN Stephanie Nee HARBOR CAPITAL ADVISORS Inc. | 28,093 | $250,440.48 | $396,813.62 | $146,373.14 | 58.45% |
| BG Bart Gancher Intech Investment Management LLC | 13,539 | $97,367.45 | $191,238.37 | $93,870.92 | 96.41% |
Bioventus Inc. Class A (BVS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Bioventus Inc. Class A ever had a stock split?
Bioventus Inc. Class A Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Robert Claypoole CEO | NASDAQ (NGS) Exchange | 09075A108 CUSIP |
| US Country | 950 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Bioventus Inc. is a pioneering medical device company that places a strong emphasis on innovating and providing treatments aimed at enhancing the body's intrinsic healing mechanisms. Operating both in the United States and internationally, the company has carved a niche for itself in the medical device industry by offering a wide range of products designed for pain management, surgical solutions, and restorative therapies. With its foundation in 2011 and headquarters in Durham, North Carolina, Bioventus stands as a beacon of advancement in leveraging medical technology to improve patient outcomes.
Products and Services
Pain Treatments: Bioventus' portfolio addresses non-surgical pain through injection therapies and peripheral nerve stimulation products. Key offerings include:
- Durolane: A treatment for knee osteoarthritis providing pain relief.
- GELSYN-3: A series of injections for knee osteoarthritis pain management.
- SUPARTZ: An injectable solution for knee osteoarthritis.
- Stimrouter: A device aimed at treating chronic peripheral pain.
Surgical Solutions: The company provides surgeons with innovative tools and biomaterials for bone and soft tissue procedures, featuring:
- Bone Graft Substitutes: Products like Osteoamp, Exponent matrix, Purebone, Signafuse bone graft, Interfuse bone graft, Osteomatrix+ synthetic bone graft, designed to stimulate bone healing.
- Ultrasonic Products: High-precision devices such as nexus ultrasonic surgical system, bonescalpel surgical solution, SonaStar, and SonicOne ultrasonic cleansing and debridement system for surgeries, including minimally invasive procedures.
- Extractor: A tool for autologous cell and bone marrow extraction to aid in bone healing.
- Reficio Bone Matrix: A novel bone graft substitute.
Restorative Therapies: Bioventus also addresses neurologic and musculoskeletal recovery, offering devices that aid in rehabilitation from strokes, multiple sclerosis, or central nervous system disorders. Products include:
- Exogen: A bone healing system.
- L300 GO: A system designed to improve foot drop conditions caused by central nervous system disorders.
- H200 Rehabilitation System: A solution to aid in regaining hand function.
- Vector: A body weight support system for gait and balance training.
- Bioness Integrated Therapy System: Offers comprehensive solutions for neurorehabilitation.
The company is also developing the Talisman Pulse Generator and Receiver, a potential breakthrough for peripheral nerve stimulation, showcasing Bioventus' commitment to ongoing innovation and improvement in the field of medical devices.
